You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim
Merck
AstraZeneca
Colorcon
McKesson

Last Updated: March 28, 2020

DrugPatentWatch Database Preview

Litigation Details for Novartis Corporation v. Teva Parenteral Medicines Inc. (D. Del. 2008)


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Novartis Corporation v. Teva Parenteral Medicines Inc. (D. Del. 2008)

Docket   Start Trial Date Filed 2008-12-18
Court District Court, D. Delaware Date Terminated 2010-08-16
Cause 35:271 Patent Infringement Assigned To Sue Lewis Robinson
Jury Demand None Referred To
Parties NOVARTIS CORPORATION; NOVARTIS PHARMACEUTICALS CORPORATION; TEVA PARENTERAL MEDICINES INC.; TEVA PHARMACEUTICAL INDUSTRIES LTD.; TEVA PHARMACEUTICALS USA INC.
Patents 4,939,130
Attorneys Allen C. Nunnally; Anne M. McLaughlin; Anne Shea Gaza; Daniel M. Esrick; Keith A. Zullow; Lisa J. Pirozzolo; Richard D. Kirk; Vinita Ferrera; William F. Lee
Firms Young, Conaway, Stargatt & Taylor LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Novartis Corporation v. Teva Parenteral Medicines Inc.
The small molecule drugs covered by the patent cited in this case are   Start Trial and   Start Trial .

Details for Novartis Corporation v. Teva Parenteral Medicines Inc. (D. Del. 2008)

Date Filed Document No. Description Snippet Link To Document
2010-08-16 20 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 4,939,130; (lid) (Entered: 08…2008 16 August 2010 1:08-cv-00952 830 Patent None District Court, D. Delaware External link to document
2008-12-19 4 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 4,939,130; (dzs, ) (Entered: …2008 16 August 2010 1:08-cv-00952 830 Patent None District Court, D. Delaware External link to document
2009-01-07 7 Count I: Infringement of United States Pategt No. 4.939.130 18. TPM repeats and incorporates herein by reference…paragraph 12. Novartis’s ‘130 Patent 13. TPM admits that on its face the ‘ 130 patent states that it is entitled…\rartis purports to bring this action under the patent laws of the United States. TPM denies the remaining…currently pending before this Court, involves the same patent being asserted in this action, and relates to ANDA…purports to bring this action under the United States Patent Laws, and admits that l\lovartis purports to base External link to document
2009-01-07 9 I: Infringement of limited States Pategt No. 4.939.130 18. 'i`eva USA repeats and incorporates herein…12. Novartis’s ‘130 Patent 13. Teva USA admits that on its face the ‘130 patent states that it is entitled…Novartis purports to bring this action under the patent laws of the United States. Teva USA denies the …currently pending before this Couit, involves the same patent being asserted in this action, and relates to ANDA…purports to bring this action under the United States Patent Laws, and admits that Novartis purports to base External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Moodys
Baxter
McKesson
Medtronic
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.